Allay Therapeutics’ Post

Allay Therapeutics was pleased to join this year’s American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting in Dallas, TX!  Allay’s CMO David Hewitt and Investigators attended AAHKS to share a poster presentation from our recently completed Phase 2B Part A study entitled “ATX101 provides sustained pain relief in TKA patients: results of a multicenter double-blind RCT." This study demonstrated compelling results on patient’s pain, opioid usage and function after TKA surgeries. These data supported the opening of our IND in the US and our dose selection for our upcoming Phase 2B Part B study.    Our team enjoyed connecting with leading experts in hip and knee surgery as we continue to transform post-surgical pain management and recuperation. Thank you to AAHKS for hosting this important event. #AAHKS #AAHKS24 #Biotech #Orthopedics

  • No alternative text description for this image
  • No alternative text description for this image
  • No alternative text description for this image

To view or add a comment, sign in

Explore topics